Anika Therapeutics Announces Date of Second-Quarter 2013 Financial Results Conference Call

  Anika Therapeutics Announces Date of Second-Quarter 2013 Financial Results
  Conference Call

Business Wire

BEDFORD, Mass. -- July 12, 2013

Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue
its second-quarter 2013 financial results after the close of the market on
Wednesday, July 31, 2013. The company plans to hold a conference call the next
day, Thursday, August 1 at 9:00 a.m. ET to discuss its financial results,
business highlights and outlook. In addition, the company will answer
questions concerning business and financial developments and trends, and other
business and financial matters affecting the company, some of the responses to
which may contain information that has not been previously disclosed.

To listen to the conference call, dial 877-546-5019 (international callers
dial 857-244-7551) and use the passcode 16226176. In addition, the call will
be available through a live audio webcast in the "Investor Relations" section
of Anika’s website, www.anikatherapeutics.com. An accompanying slide
presentation also can be accessed via the Anika Therapeutics website. The call
will be archived and accessible on the same website shortly after its
conclusion.

About Anika Therapeutics, Inc.

Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops,
manufactures and commercializes therapeutic products for tissue protection,
healing, and repair. These products are based on hyaluronic acid (HA), a
naturally occurring, biocompatible polymer found throughout the body. Anika’s
products range from orthopedic/joint health solutions led by Orthovisc^®, a
treatment for osteoarthritis of the knee; to surgical aids in the
anti-adhesion and ophthalmic fields. The company also offers aesthetic dermal
fillers for the correction of facial wrinkles. Anika’s Italian subsidiary,
Anika Therapeutics, S.r.l., provides complementary HA products in
orthopedic/joint health and anti-adhesion, as well as therapeutics in areas
such as advanced wound treatment and ear, nose and throat care. Its
regenerative technology advances Anika’s vision to offer therapeutic products
that go beyond pain relief to protect and restore damaged tissue.

Contact:

Anika Therapeutics, Inc.
Charles H. Sherwood, Ph.D., 781-457-9000
President and CEO
or
Sylvia Cheung, 781-457-9000
CFO
 
Press spacebar to pause and continue. Press esc to stop.